Information de reference pour ce titreAccession Number: | 00043764-200203000-00010.
|
Author: | Pegus, Cheryl MD, MPH; Bazzarre, Terry L. PhD; Brown, Jeffrey S. MA; Menzin, Joseph PhD
|
Institution: | From Pfizer, Inc, New York, N.Y. (Dr Pegus); The Robert Wood Johnson Foundation, Princeton, N.J. (Dr Bazzarre); and Boston Health Economics, Inc, Waltham, Mass (Mr Brown, Dr Menzin).
|
Title: | |
Source: | Journal of Occupational & Environmental Medicine. 44(3):228-236, March 2002.
|
Abstract: | This study evaluates the effects of the American Heart Association's Heart At Work program on cardiovascular disease risk factor awareness, self-efficacy, and health behaviors. A prospective, quasi-experimental research design was used to assess the impact of the program at two factory sites (one intervention and one control). A total of 633 employees participated. Intervention site respondents significantly improved their knowledge of blood pressure management, the relationship between nutrition and cardiovascular disease, and heart attack risk factors. They also were more likely to begin treatment for hypertension, to report fewer sick days, and to have plans to improve their diet and lose weight. These findings suggest that the Heart At Work program had a favorable overall impact.
(C)2002The American College of Occupational and Environmental Medicine
|
References: | 1. American Heart Association. 2001 Heart and Stroke Statistical Update. Dallas, Texas: AHA; 2000.
2. Grundy SM. Primary prevention of coronary heart disease. J Intern Med. 1997; 241: 295-306.
3. Grundy SM. Cholesterol and coronary heart disease. Arch Intern Med. 1997; 157: 1177-1184.
4. National Cholesterol Education Program in Adults. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary. Washington, DC: National Heart, Lung, and Blood Institute, National Institutes of Health; 2001.
5. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000; 342: 145-153.
6. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000; 355: 253-259.
7. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998; 351: 1755-1762.
8. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995; 333: 1301-1307.
9. Hu FB, Stampfer MJ, Solomon C, et al. Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med. 2001; 134: 96-105.
10. NIH Consensus Development Panel on Physical Activity and Cardiovascular Health. Physical activity and cardiovascular health. JAMA. 1996; 276: 241-246.
11. US Preventive Services Task Force. Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1996: 531-540.
12. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women. JAMA. 1993; 269: 232-236.
13. Wannamethee SG, Shaper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA. 1995; 274: 155-160.
14. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the JNC on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, MD: National Institutes of Health; 1997.Report no. 98-4080.
15. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995; 25: 305-313.
16. Sempos CT, Cleeman JI, Carroll MD, et al. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel [see comments]. JAMA. 1993; 269: 3009-3014.
17. Hoerger TJ, Bala MV, Bray JW, Wilcosky TC, LaRosa J. Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults. Am J Cardiol. 1998; 82: 61-65.
18. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 1994: 272: 205-211.
19. Giles WH. Recent trends in the identification and treatment of high blood cholesterol by physicians: progress and missed opportunities. JAMA. 1993; 269: 1133-1138.
20. Fries JF, Koop CE, Beadle CE, et al. Reducing health care costs by reducing the need and demand for medical services. The Health Project Consortium. N Engl J Med. 1993; 329: 321-325.
21. Stokols D, Pelletier KR, Fielding JE. Integration of medical care and worksite health promotion. JAMA. 1995; 273: 1136-1142.
22. US Department of Labor. Current labor statistics. Monthly Labor Rev. 2001; 124: 63-122.
23. Cowan CA, Braden BR. Business, households, and government: health care spending, 1995. Health Care Finance Rev. 1997; 18: 195-206.
24. Grosch JW, Alterman T, Petersen MR, Murphy LR. Worksite health promotion programs in the US: factors associated with availability and participation. Am J Health Promot. 1998; 13: 36-45.
25. Cook TD, Campbell DT. Quasi-Experimentation Design and Analysis Issues for Field Settings. Skokie, IL: Rand McNally; 1979.
26. Pelletier KR. A review and analysis of the clinical and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: 1996-1998 update (IV). Am J Health Promot. 1999; 13: 333-345.
27. Bandura A. Social cognitive theory of self-regulation. Organizational Behavior and Human Decision Processes. 1991; 50: 248-287.
28. Ajzen I. The theory of planned behavior. Organizational Behavior and Human Decision Processes. 1991; 50: 179-211.
29. Emmons KM, Linnan LA, Shadel WG, Marcus B, Abrams DB. The Working Healthy Project: a worksite health-promotion trial targeting physical activity, diet, and smoking. J Occup Environ Med. 1999; 41: 545-555.
30. Braeckman L, De Bacquer D, Maes L, De Backer G. Effects of a low-intensity worksite-based nutrition intervention. Occup Med (Oxf). 1999; 49: 549-555.
31. Perovich SJ, Sandoval MW. Outcomes of a worksite cholesterol education program over a 5-year period. J Am Diet Assoc. 1995; 95: 589-590.
32. Dishman RK, Oldenburg B, O'Neal H, Shephard RJ. Worksite physical activity interventions. Am J Prev Med. 1998; 15: 344-361.
33. Heaney CA, Goetzel RZ. A review of health-related outcomes of multi-component worksite health promotion programs. Am J Health Promot. 1997; 11: 290-307.
34. Glanz K, Sorensen G, Farmer A. The health impact of worksite nutrition and cholesterol intervention programs. Am J Health Promot. 1997; 10: 453-470.
35. Glasgow RE, Terborg JR, Strycker LA, Boles SM, Hollis JF. Take Heart II: replication of a worksite health promotion trial. J Behav Med. 1997; 20: 143-161.
36. Sorensen G, Stoddard A, Hunt MK, et al. The effects of a health promotion-health protection intervention on behavior change: the WellWorks Study. Am J Public Health. 1998; 88: 1685-1690.
37. Streiner DL, Norman GR. Health Measurements Scales. A Practical Guide to Their Development and Use. 2nd ed. New York: Oxford University Press; 1995.
|
Language: | English.
|
Document Type: | Original Articles.
|
Journal Subset: | Clinical Medicine. Behavioral & Social Sciences. Life Sciences.
|
ISSN: | 1076-2752
|
NLM Journal Code: | B7H
|
Annotation(s) | |
|
|